Provided by Tiger Trade Technology Pte. Ltd.

Agenus

7.99
+0.38004.99%
Pre-market: 8.050.0600+0.75%08:20 EDT
Volume:676.56K
Turnover:5.31M
Market Cap:359.71M
PE:3.20
High:8.00
Open:7.56
Low:7.54
Close:7.61
52wk High:8.85
52wk Low:2.71
Shares:45.02M
Float Shares:42.21M
Volume Ratio:0.80
T/O Rate:1.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.50
EPS(LYR):-0.0034
ROE:-1278.83%
ROA:12.53%
PB:-1.81
PE(LYR):-2,352.77

Loading ...

Agenus Joins Cantor Global Healthcare Conference Fireside Chat

Reuters
·
Aug 31

Agenus Reports 21.2-Month Median Survival in Phase 1b Bot+bal Study for MSS Metastatic Colorectal Cancer

Reuters
·
Aug 28

Agenus: No colorectal cancer recurrences observed at updated follow-up in trial

TIPRANKS
·
Aug 26

Agenus Reports no Recurrences in Phase 2 NEST Trial of Botensilimab Plus Balstilimab in Resectable Colon Cancer

Reuters
·
Aug 26

Agenus Posts Investor Deck Spotlighting Botensilimab-Balstilimab Neoadjuvant Program in MSS Colon Cancer

Reuters
·
Aug 21

Agenus Modifies Loan and Issues Unregistered Equity

TIPRANKS
·
Aug 19

Agenus - Unit Enters Second Loan Modification Agreement with Ocean 1181 on Aug 12, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 19

Agenus - Loan Principal $24.75 Mln, Maturity Extended to Nov 30, 2029, Interest 13.0% Per Annum - SEC Filing

THOMSON REUTERS
·
Aug 19

Agenus Extends $24.75 Million Loan Maturity to Nov. 2029 in Ocean 1181 Amendment

Reuters
·
Aug 19

Agenus Grants CEO Garo Armen 1,971,500 Performance-Based Stock Options at $7.78 Per Share

Reuters
·
Aug 13

Agenus Strengthens Board With New Director Appointment

TIPRANKS
·
Aug 12

Agenus Tunjuk Marco Tullio Marcucci Sebagai Direktur Baru Dewan Komisaris

Reuters
·
Aug 12

Agenus Price Target Cut to $25.00/Share from $30.00 by HC Wainwright & Co.

Dow Jones
·
Aug 11

Agenus Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 08

Agenus Files for Resale of Up to 78 Million Shares

MT Newswires Live
·
Aug 08

Agenus - Offers up to 77,976,718 Shares of Common Stock by Selling Securityholders - SEC Filing

THOMSON REUTERS
·
Aug 08

Xenetic Biosciences Q2 Royalty Revenue Rises on Takeda Sublicense

Reuters
·
Aug 07

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 07

Agenus Q2 Revenue Rises on Access and Royalty Income

Reuters
·
Aug 06

Agenus Swings to Q2 FY26 Net Loss of $0.6 Million; Revenue Rises 34.24% to $34.5 Million Year-over-Year

Reuters
·
Aug 06